Mikhail Naum Kosiborod (Mikhail N Kosiborod, Mikhail Kosiborod)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 90

Top Topics

Cardiovascular Disease

Ejection Fraction

Top Venues

Diabetes, obesity & metabolism

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Sanjay Rajagopalan, Armando Vergara-Martel, Jeffrey Zhong, Haitham Khraishah, Mikhail Naum Kosiborod, Ian J Neeland, Jean-Eudes Dazard, Zhuo Chen, Thomas Munzel, Robert D Brook, Mark Nieuwenhuijsen, Peter Hovmand, Sadeer G Al-Kindi
The Urban Environment and Cardiometabolic Health. Circulation 149 (16) (2024)
Jiten P Vora, David Z I Cherney, Mikhail Naum Kosiborod, Jonas Spaak, Naresh Kanumilli, Kamlesh Khunti F MedSci, Carolyn Su Ping Lam, Michael Bachmann, Peter Fenici, null null
Inter-relationships between cardiovascular, renal and metabolic diseases: Underlying evidence and implications for integrated interdisciplinary care and management. Diabetes, obesity & metabolism (2024)
Niteesh K Choudhry, Muthiah Vaduganathan, Brian Lee Claggett, Ian J Kulac, Inder S Anand, Akshay S Desai, James C Fang, Adrian F Hernandez, Pardeep S Jhund, Mikhail Naum Kosiborod, Marc S Sabatine, Sanjiv J Shah, Orly Vardeny, John Joseph Valentine McMurray, Scott D Solomon, Thomas Andrew Gaziano
Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials. Journal of the American Heart Association (2024)
Muthiah Vaduganathan, Christopher P Cannon, Meg J Jardine, Hiddo J L Heerspink, Clare Arnott, Brendon L Neuen, Ashish Sarraju, Jagadish Gogate, Jochen Seufert, Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Mikhail Naum Kosiborod
Effects of canagliflozin on total heart failure events across the kidney function spectrum: Participant-level pooled analysis from the CANVAS Program and CREDENCE trial. European journal of heart failure (2024)
Mikhail Naum Kosiborod, Mark Colquhoun Petrie, Barry A Borlaug
Response by Kosiborod et al to Letter Regarding Article, "Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial". Circulation 150 (10) (2024)
Steven N Fishbane, Juan Jesús Carrero, Supriya Kumar, Eiichiro Kanda, Katarina Hedman, Richard Ofori-Asenso, Naoki Kashihara, Mikhail Naum Kosiborod, Mitja Lainscak, Carol A Pollock, Stenvinkel Peter, David Collins Wheeler, Roberto Pecoits-Filho
Hyperkalemia Burden and Treatment Pathways in Patients with CKD: Findings From the DISCOVER CKD Retrospective Cohort. Kidney360 5 (7) (2024)
Steven N Fishbane, Juan Jesús Carrero, Supriya Kumar, Eiichiro Kanda, Katarina Hedman, Richard Ofori-Asenso, Naoki Kashihara, Mikhail Naum Kosiborod, Mitja Lainscak, Carol A Pollock, Stenvinkel Peter, David Collins Wheeler, Roberto Pecoits-Filho
Hyperkalemia Burden and Treatment Pathways in Patients with CKD: Findings From the DISCOVER CKD Retrospective Cohort. Kidney360 5 (7) (2024)
Niteesh K Choudhry, Muthiah Vaduganathan, Brian Lee Claggett, Ian J Kulac, Inder S Anand, Akshay S Desai, James C Fang, Adrian F Hernandez, Pardeep S Jhund, Mikhail Naum Kosiborod, Marc S Sabatine, Sanjiv J Shah, Orly Vardeny, John Joseph Valentine McMurray, Scott D Solomon, Thomas Andrew Gaziano
Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials. Journal of the American Heart Association 13 (5) (2024)
Steven N Fishbane, Juan Jesús Carrero, Supriya Kumar, Eiichiro Kanda, Katarina Hedman, Richard Ofori-Asenso, Naoki Kashihara, Mikhail Naum Kosiborod, Mitja Lainscak, Carol A Pollock, Stenvinkel Peter, David Collins Wheeler, Roberto Pecoits-Filho
Hyperkalemia Burden and Treatment Pathways in Patients with CKD: Findings From the DISCOVER CKD Retrospective Cohort. Kidney360 5 (7) (2024)
Niteesh K Choudhry, Muthiah Vaduganathan, Brian Lee Claggett, Ian J Kulac, Inder S Anand, Akshay S Desai, James C Fang, Adrian F Hernandez, Pardeep S Jhund, Mikhail Naum Kosiborod, Marc S Sabatine, Sanjiv J Shah, Orly Vardeny, John Joseph Valentine McMurray, Scott D Solomon, Thomas Andrew Gaziano
Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials. Journal of the American Heart Association 13 (5) (2024)
Sanjiv J Shah, Kavita Sharma, Barry A Borlaug, Javed Butler, Melanie Davies, Dalane W Kitzman, Mark C Petrie, Subodh Verma, Shachi Patel, Khaja M Chinnakondepalli, Mette N Einfeldt, Thomas J Jensen, Søren Rasmussen, Rabea Asleh, Tuvia Ben-Gal, Mikhail Naum Kosiborod
Semaglutide and Diuretic Use in Obesity-Related Heart Failure with Preserved Ejection Fraction: A Pooled Analysis of the STEP-HFpEF and STEP-HFpEF-DM trials. European heart journal (2024)
Niteesh K Choudhry, Muthiah Vaduganathan, Brian Lee Claggett, Ian J Kulac, Inder S Anand, Akshay S Desai, James C Fang, Adrian F Hernandez, Pardeep S Jhund, Mikhail Naum Kosiborod, Marc S Sabatine, Sanjiv J Shah, Orly Vardeny, John Joseph Valentine McMurray, Scott D Solomon, Thomas Andrew Gaziano
Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials. Journal of the American Heart Association 13 (5) (2024)
Sanjay Rajagopalan, Armando Vergara-Martel, Jeffrey Zhong, Haitham Khraishah, Mikhail Naum Kosiborod, Ian J Neeland, Jean-Eudes Dazard, Zhuo Chen, Thomas Munzel, Robert D Brook, Mark Nieuwenhuijsen, Peter Hovmand, Sadeer G Al-Kindi
The Urban Environment and Cardiometabolic Health. Circulation 149 (16) (2024)
Niteesh K Choudhry, Muthiah Vaduganathan, Brian Lee Claggett, Ian J Kulac, Inder S Anand, Akshay S Desai, James C Fang, Adrian F Hernandez, Pardeep S Jhund, Mikhail Naum Kosiborod, Marc S Sabatine, Sanjiv J Shah, Orly Vardeny, John Joseph Valentine McMurray, Scott D Solomon, Thomas Andrew Gaziano
Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials. Journal of the American Heart Association 13 (5) (2024)
Jiten P Vora, David Z I Cherney, Mikhail Naum Kosiborod, Jonas Spaak, Naresh Kanumilli, Kamlesh Khunti F MedSci, Carolyn Su Ping Lam, Michael Bachmann, Peter Fenici, null null
Inter-relationships between cardiovascular, renal and metabolic diseases: Underlying evidence and implications for integrated interdisciplinary care and management. Diabetes, obesity & metabolism 26 (5) (2024)
Sanjay Rajagopalan, Armando Vergara-Martel, Jeffrey Zhong, Haitham Khraishah, Mikhail Naum Kosiborod, Ian J Neeland, Jean-Eudes Dazard, Zhuo Chen, Thomas Munzel, Robert D Brook, Mark Nieuwenhuijsen, Peter Hovmand, Sadeer G Al-Kindi
The Urban Environment and Cardiometabolic Health. Circulation 149 (16) (2024)
Niteesh K Choudhry, Muthiah Vaduganathan, Brian Lee Claggett, Ian J Kulac, Inder S Anand, Akshay S Desai, James C Fang, Adrian F Hernandez, Pardeep S Jhund, Mikhail Naum Kosiborod, Marc S Sabatine, Sanjiv J Shah, Orly Vardeny, John Joseph Valentine McMurray, Scott D Solomon, Thomas Andrew Gaziano
Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials. Journal of the American Heart Association 13 (5) (2024)
Steven N Fishbane, Juan Jesús Carrero, Supriya Kumar, Eiichiro Kanda, Katarina Hedman, Richard Ofori-Asenso, Naoki Kashihara, Mikhail Naum Kosiborod, Mitja Lainscak, Carol A Pollock, Stenvinkel Peter, David Collins Wheeler, Roberto Pecoits-Filho
Hyperkalemia Burden and Treatment Pathways in Patients with CKD: Findings From the DISCOVER CKD Retrospective Cohort. Kidney360 5 (7) (2024)
Jiten P Vora, David Z I Cherney, Mikhail Naum Kosiborod, Jonas Spaak, Naresh Kanumilli, Kamlesh Khunti F MedSci, Carolyn Su Ping Lam, Michael Bachmann, Peter Fenici, null null
Inter-relationships between cardiovascular, renal and metabolic diseases: Underlying evidence and implications for integrated interdisciplinary care and management. Diabetes, obesity & metabolism 26 (5) (2024)
Sanjay Rajagopalan, Armando Vergara-Martel, Jeffrey Zhong, Haitham Khraishah, Mikhail Naum Kosiborod, Ian J Neeland, Jean-Eudes Dazard, Zhuo Chen, Thomas Munzel, Robert D Brook, Mark Nieuwenhuijsen, Peter Hovmand, Sadeer G Al-Kindi
The Urban Environment and Cardiometabolic Health. Circulation 149 (16) (2024)
Ildiko Lingvay, Vanita R Aroda, Julie Broe Honoré, Anne S Ersbøll, Lise Lotte Nystrup Husemoen, Anders Boeck Jensen, Kasper Sommer Matthiessen, Mikhail Naum Kosiborod
Patterns of new glucagon-like peptide-1 receptor agonist use in patients with type 2 diabetes during 2014-2019 from a US database: prescriber and patient characteristics. Journal of diabetes 15 (2) (2023)
Safia Chatur, Muthiah Vaduganathan, Brian Lee Claggett, Jonathan W Cunningham, Kieran F Docherty, Akshay S Desai, Pardeep S Jhund, Rudolf A de Boer, Adrian F Hernandez, Catherine M Viscoli, Mikhail Naum Kosiborod, Carolyn Su Ping Lam, Felipe A Martinez, Sanjiv J Shah, Magnus Petersson, Anna-Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial. Circulation (2023)
Toru Kondo, Karola S Jering, C Jan Willem Borleffs, Rudolf A de Boer, Brian Lee Claggett, Akshay S Desai, Dan Dobreanu, Catherine M Viscoli, Adrian F Hernandez, Stefan P Janssens, Pardeep S Jhund, Mikhail Naum Kosiborod, Carolyn Su Ping Lam, Anna Maria Langkilde, Felipe A Martinez, Magnus Petersson, Pham Nguyen Vinh, Muthiah Vaduganathan, Scott D Solomon, John Joseph Valentine McMurray
Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial. Circulation (2023)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine (2023)
Toru Kondo, Jawad Haider Butt, James P Curtain, Pardeep S Jhund, Kieran F Docherty, Brian Lee Claggett, Muthiah Vaduganathan, Erasmus Bachus, Adrian F Hernandez, Carolyn S P Lam, Catherine M Viscoli, Felipe A Martinez, Rudolf A de Boer, Mikhail Naum Kosiborod, Akshay S Desai, Lars Valeur Køber, Piotr Ponikowski, Marc S Sabatine, Scott D Solomon, John Joseph Valentine McMurray
Efficacy of Dapagliflozin According to Heart Rate: A Patient-Level Pooled Analysis of DAPA-HF and DELIVER. Circulation. Heart failure (2023)
Gregory D Lewis, Kensey L Gosch, Laura P Cohen, Michael E Nassif, Sheryl L Windsor, Barry A Borlaug, Dalane W Kitzman, Sanjiv J Shah, Taiyeb Khumri, Guillermo E Umpierrez, Sumant Lamba, Kavita Sharma, Sadiya S Khan, Mikhail Naum Kosiborod, Andrew J Sauer
Effect of Dapagliflozin on 6-Minute Walk Distance in Heart Failure With Preserved Ejection Fraction: PRESERVED-HF. Circulation. Heart failure (2023)
Senthil Selvaraj, Mikhail Naum Kosiborod, Svati H Shah
Response by Selvaraj et al to Letter Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF". Circulation 147 (11) (2023)
John W Ostrominski, Muthiah Vaduganathan, Senthil Selvaraj, Brian Lee Claggett, Zi Michael Miao, Akshay S Desai, Pardeep S Jhund, Mikhail Naum Kosiborod, Carolyn Su Ping Lam, Catherine M Viscoli, Felipe A Martinez, Rudolf A de Boer, Adrian F Hernandez, Sanjiv J Shah, Magnus Petersson, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial. Circulation (2023)
Suzanne V Arnold, James A de Lemos, Luke Zheng, Robert S Rosenson, Christie M Ballantyne, Shushama Alam, Deepak L Bhatt, Christopher P Cannon, Mikhail Naum Kosiborod, null null
Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort study. Diabetes, obesity & metabolism (2023)
Ildiko Lingvay, Vanita R Aroda, Julie Broe Honoré, Anne S Ersbøll, Lise Lotte Nystrup Husemoen, Anders Boeck Jensen, Kasper Sommer Matthiessen, Mikhail Naum Kosiborod
Patterns of new glucagon-like peptide-1 receptor agonist use in patients with type 2 diabetes during 2014-2019 from a US database: prescriber and patient characteristics. Journal of diabetes 15 (2) (2023)
Scott D Solomon, Charles J Lowenstein, Ankeet S Bhatt, Alexander Peikert, Orly Vardeny, Mikhail Naum Kosiborod, Jeffrey S Berger, Harmony R Reynolds, Stephanie Mavromichalis, Anya Barytol, Andrew D Althouse, James F Luther, Eric S Leifer, Andrei L Kindzelski, Andrea N Edginton, Michelle Ng Gong, Lucy Z Kornblith, Pooja Khatri, Keri S Kim, Lisa Baumann Kreuziger, Lana Wahid, Bridget-Anne Kirwan, Mark W Geraci, Matthew D Neal, Judith S Hochman, null null
Effect of the P-selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial. Circulation (2023)
Suzanne V Arnold, James A de Lemos, Luke Zheng, Robert S Rosenson, Christie M Ballantyne, Shushama Alam, Deepak L Bhatt, Christopher P Cannon, Mikhail Naum Kosiborod, null null
Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort study. Diabetes, obesity & metabolism (2023)
Barry A Borlaug, Dalane W Kitzman, Melanie J Davies, Søren Rasmussen, Eric Barros, Javed Butler, Mette Nygaard Einfeldt, G Kees Hovingh, Daniél Vega Møller, Mark C Petrie, Sanjiv J Shah, Subodh Verma, Walter P Abhayaratna, Fozia Z Ahmed, Vijay Chopra, Justin A Ezekowitz, Michael Fu, Hiroshi Ito, Małgorzata Lelonek, Vojtech Melenovsky, Julio Nunez, Eduardo Roque Perna, Morten Schou, Michele Senni, Peter Van der Meer, Dirk von Lewinski, Dennis Wolf, Mikhail Naum Kosiborod
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial. Nature medicine (2023)
Ildiko Lingvay, Vanita R Aroda, Julie Broe Honoré, Anne S Ersbøll, Lise Lotte Nystrup Husemoen, Anders Boeck Jensen, Kasper Sommer Matthiessen, Mikhail Naum Kosiborod
Patterns of new glucagon-like peptide-1 receptor agonist use in patients with type 2 diabetes during 2014-2019 from a US database: prescriber and patient characteristics. Journal of diabetes 15 (2) (2023)
Michael E Nassif, Sheryl L Windsor, Kensey L Gosch, Barry A Borlaug, Mansoor Husain, Catherine M Viscoli, Dalane W Kitzman, Darren K McGuire, Bertram Pitt, Benjamin M Scirica, Sanjiv J Shah, Guillermo Umpierrez, Bethany A Austin, Sumant Lamba, Taiyeb Khumri, Kavita Sharma, Mikhail Naum Kosiborod
Dapagliflozin Improves Heart Failure Symptoms and Physical Limitations Across the Full Range of Ejection Fraction: Pooled Patient-Level Analysis From DEFINE-HF and PRESERVED-HF Trials. Circulation. Heart failure (2023)
Senthil Selvaraj, Mikhail Naum Kosiborod, Svati H Shah
Response by Selvaraj et al to Letter Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF". Circulation 147 (11) (2023)
Su Ern Yeoh, Kieran F Docherty, Ross T Campbell, Pardeep S Jhund, Ann Hammarstedt, Hiddo J Lambers Heerspink, Petr Jarolim, Lars Valeur Køber, Mikhail Naum Kosiborod, Felipe A Martinez, Piotr Ponikowski, Scott D Solomon, Mikaela Sjöstrand, Olof F Bengtsson, Peter J Greasley, Naveed Sattar, Paul I Welsh, Marc S Sabatine, David A Morrow, John Joseph Valentine McMurray
Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HF. Circulation (2023)
Mikhail Naum Kosiborod, Subodh Verma, Barry A Borlaug, Javed Butler, Melanie J Davies, Thomas Jon Jensen, Søren Rasmussen, Peter Erlang Marstrand, Mark Colquhoun Petrie, Sanjiv J Shah, Hiroshi Ito, Morten Schou, Vojtech Melenovsky, Walter P Abhayaratna, Dalane W Kitzman
Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients with Heart Failure with Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial. Circulation (2023)
Kashvi Gupta, John A Spertus, Mary Birmingham, Kensey L Gosch, Mansoor Husain, Dalane W Kitzman, Bertram Pitt, Sanjiv J Shah, James L Januzzi, Ildiko Lingvay, Javed Butler, Mikhail Naum Kosiborod, David E Lanfear
Racial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium-Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF Trials. Circulation (2023)
John Joseph Valentine McMurray, Kieran F Docherty, Rudolf A de Boer, Ann Hammarstedt, Dalane W Kitzman, Mikhail Naum Kosiborod, Anna Maria Langkilde, Barry Reicher, Michele Senni, Sanjiv J Shah, Ulrica Wilderäng, Subodh Verma, Scott D Solomon
Effect of Dapagliflozin Versus Placebo on Symptoms and 6-Minute Walk Distance in Patients With Heart Failure: The DETERMINE Randomized Clinical Trials. Circulation (2023)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine (2023)
Kamlesh Khunti F MedSci, Yuehuan Chung, Jim Davies, Benjamin C T Field, Sophie Harris, Mikhail Naum Kosiborod, Dinesh Nagi, Parth Narendran, Dipesh Patel, Robert E J Ryder, Kinga A Várnai, Sarah D Wild, Emma G Wilmot, Rustam D Rea, null null
Association Between SGLT2 Inhibitor Treatment and Diabetic Ketoacidosis and Mortality in People With Type 2 Diabetes Admitted to Hospital With COVID-19. Diabetes care (2022)
Carly Adamson, Kieran F Docherty, Hiddo J Lambers Heerspink, Rudolf A de Boer, Kevin Damman, Catherine M Viscoli, Lars Valeur Køber, Mikhail Naum Kosiborod, Felipe A Martinez, Mark Colquhoun Petrie, Piotr Ponikowski, Marc S Sabatine, Morten Schou, Scott D Solomon, Subodh Verma, Olof F Bengtsson, Anna Maria Langkilde, Mikaela Sjöstrand, Muthiah Vaduganathan, Pardeep S Jhund, John Joseph Valentine McMurray
Initial Decline (Dip) in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From DAPA-HF. Circulation 146 (6) (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Kieran F Docherty, Paul I Welsh, Subodh Verma, Rudolf A de Boer, Eileen O'Meara, Olof F Bengtsson, Lars Valeur Køber, Mikhail Naum Kosiborod, Ann Hammarstedt, Anna Maria Langkilde, Daniel Lindholm, Dustin J Little, Mikaela Sjöstrand, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, David A Morrow, Morten Schou, Scott D Solomon, Naveed Sattar, Pardeep S Jhund, John Joseph Valentine McMurray, null null
Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF. Circulation 146 (13) (2022)
Alexander Peikert, Felipe A Martinez, Muthiah Vaduganathan, Brian Lee Claggett, Ian J Kulac, Akshay S Desai, Pardeep S Jhund, Rudolf A de Boer, David L DeMets, Adrian F Hernandez, Catherine M Viscoli, Mikhail Naum Kosiborod, Carolyn Su Ping Lam, Sanjiv J Shah, Tsvetana Katova, Béla Merkely, Orly Vardeny, Ulrica Wilderäng, Daniel Lindholm, Magnus Petersson, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Efficacy and Safety of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Age: The DELIVER Trial. Circulation. Heart failure 15 (10) (2022)
Carolyn S P Lam, Christiane E Angermann, John R Teerlink, Sean P Collins, Mikhail Naum Kosiborod, Jan Biegus, João Pedro Ferreira, Michael E Nassif, Mitchell A Psotka, Jasper Tromp, C Jan Willem Borleffs, Changsheng Ma, Joseph Comin-Colet, Michael Fu, Stefan P Janssens, Robert G Kiss, Robert J Mentz, Yasushi Sakata, Henrik Schirmer, Morten Schou, P Christian Schulze, Lenka Spinarova, Maurizio Volterrani, Jerzy Krzysztof Wranicz, Uwe Zeymer, Shelley Zieroth, Martina Brueckmann, Jonathan P Blatchford, Afshin Salsali, Piotr Ponikowski
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial. Nature medicine 28 (3) (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Xiaowen Wang, Muthiah Vaduganathan, Brian Lee Claggett, Sheila M Hegde, Maria Pabon, Ian J Kulac, Orly Vardeny, Eileen O'Meara, Shelley Zieroth, Tzvetana Katova, Martina M McGrath, Anne-Catherine Pouleur, Pardeep S Jhund, Akshay S Desai, Catherine M Viscoli, Mikhail Naum Kosiborod, Rudolf A de Boer, Lars Valeur Køber, Marc S Sabatine, Felipe A Martinez, Piotr Ponikowski, Sanjiv J Shah, Adrian F Hernandez, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon, Carolyn Su Ping Lam
Sex Differences in Characteristics, Outcomes and Treatment Response with Dapagliflozin across the Range of Ejection Fraction in Patients with Heart Failure: Insights from DAPA-HF and DELIVER. Circulation (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Mikhail Naum Kosiborod, Christiane E Angermann, Sean P Collins, John R Teerlink, Piotr Ponikowski, Jan Biegus, Josep Comín Colet, Joao Pedro Ferreira, Robert J Mentz, Michael E Nassif, Mitchell A Psotka, Jasper Tromp, Martina Brueckmann, Jonathan P Blatchford, Afshin Salsali, Carolyn S P Lam
Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial. Circulation 146 (4) (2022)
Jawad H Butt, Pardeep S Jhund, Jan Belohlávek, Rudolf A de Boer, Chern-En Chiang, Akshay S Desai, Jarosław Drożdż, Adrian F Hernandez, Catherine M Viscoli, Tzvetana Katova, Masafumi Kitakaze, Mikhail Naum Kosiborod, Carolyn Su Ping Lam, Anna Maria Langkilde, Daniel Lindholm, Erasmus Bachus, Felipe A Martinez, Bela Merkely, Magnus Petersson, Jose F Kerr Saraiva, Sanjiv J Shah, Muthiah Vaduganathan, Orly Vardeny, Ulrica Wilderäng, Brian Lee Claggett, Scott D Solomon, John Joseph Valentine McMurray
Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial. Circulation 146 (16) (2022)
Senthil Selvaraj, Zhuxuan Fu, Phillip G Jones, Lydia Coulter Kwee, Sheryl L Windsor, Olga R Ilkayeva, Christopher B Newgard, Kenneth B Margulies, Mansoor Husain, Catherine M Viscoli, Darren K McGuire, Bertram Pitt, Benjamin M Scirica, David E Lanfear, Michael E Nassif, Ali Javaheri, Robert J Mentz, Mikhail Naum Kosiborod, Svati H Shah, null null
Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF. Circulation 146 (11) (2022)
Mikhail Naum Kosiborod, Meena Bhatta, Melanie Jane Davies, John E Deanfield, W Timothy Garvey, Usman Khalid, Robert Kushner, Domenica M Rubino, Niels Zeuthen, Subodh Verma
Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses. Diabetes, obesity & metabolism (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Kim A Connelly, C David Mazer, Pankaj Puar, Hwee Teoh, Chao-Hung Wang, Tamique Mason, Farhad Akhavein, Ching-Wen Chang, Min-Hui Liu, Ning-I Yang, Wei-Siang Chen, Yu-Hsiang Juan, Erika Opingari, Yaseen Salyani, William Barbour, Aryan Pasricha, Shamon Ahmed, Andrew Kosmopoulos, Raj Verma, Michael Moroney, Ehab Bakbak, Aishwarya Krishnaraj, Deepak L Bhatt, Javed Butler, Mikhail Naum Kosiborod, Carolyn Su Ping Lam, David A Hess, Otávio Rizzi Coelho-Filho, Myriam Lafreniere-Roula, Kevin E Thorpe, Adrian Quan, Lawrence Alan Leiter, Andrew T Yan, Subodh Verma
Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial. Circulation (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Suping Ling, Francesco Zaccardi, Bogdan Vlacho, Ping Li, Jordi Real Gatius, Manel Mata-Cases, Josep Franch-Nadal, Mikhail Naum Kosiborod, Clare Gillies, Peter Fenici, Esmeralda Castelblanco, Baiju R Shah, Kamlesh Khunti F MedSci
All-cause and cardiorenal mortality in 6 million adults with and without type 2 diabetes: A comparative, trend analysis in Canada, Spain, and the UK. Diabetes, obesity & metabolism (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Kamlesh Khunti F MedSci, Vanita R Aroda, Deepak L Bhatt, Biykem Bozkurt, John B Buse, Hiddo J Lambers Heerspink, Catherine M Viscoli, Carolyn Su Ping Lam, Nikolaus Marx, John Joseph Valentine McMurray, Scott D Solomon, Mikhail Naum Kosiborod
Re-examining the widespread policy of stopping sodium-glucose cotransporter-2 inhibitors during acute illness: A perspective based on the updated evidence. Diabetes, obesity & metabolism 24 (11) (2022)
John A Spertus, Mary C Birmingham, Michael Nassif, C V Damaraju, Antonio Abbate, Javed Butler, David E Lanfear, Ildiko Lingvay, Mikhail Naum Kosiborod, James L Januzzi
The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial. Nature medicine 28 (4) (2022)
Pardeep S Jhund, Toru Kondo, Jawad Haider Butt, Kieran F Docherty, Brian L Claggett, Akshay S Desai, Muthiah Vaduganathan, Samvel B Gasparyan, Olof F Bengtsson, Daniel Lindholm, Magnus Petersson, Anna Maria Langkilde, Rudolf A de Boer, David DeMets, Adrian F Hernandez, Silvio E Inzucchi, Mikhail Naum Kosiborod, Lars Valeur Køber, Carolyn Su Ping Lam, Felipe A Martinez, Marc S Sabatine, Sanjiv J Shah, Scott D Solomon, John Joseph Valentine McMurray
Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER. Nature medicine 28 (9) (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Ewa Anita Jankowska, Bridget-Anne Kirwan, Mikhail Naum Kosiborod, Javed Butler, Stefan D Anker, Theresa McDonagh, Maria Dorobantu, Jarosław Drożdż, Gerasimos S Filippatos, Andre Keren, Irakli Khintibidze, Hans Kragten, Felipe A Martinez, Marco Metra, Davor Milicic, Jose Carlos Nicolau, Marcus Ohlsson, Alexander Parkhomenko, Domingo Pascual Figal, Frank Ruschitzka, David Sim, Hadi Skouri, Peter van der Meer, Basil S Lewis, Josep Comín Colet, Stephan von Haehling, Alain Cohen-Solal, Tabassome Simon, Wolfram Döhner, Henry J Dargie, Michael Motro, Tim Friede, Vincent Fabien, Fabio Dorigotti, Stuart J Pocock, Piotr Ponikowski
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study. European heart journal (2021)
Michael E Nassif, John A Spertus, Fengming Tang, Sheryl L Windsor, Phillip G Jones, Merrill Thomas, Yevgeniy Khariton, John Brush, Robert A Gordon, Rita Jermyn, Orvar Jonsson, Sumant Lamba, David M Shavelle, Mikhail Naum Kosiborod
Association Between Change in Ambulatory Hemodynamic Pressures and Symptoms of Heart Failure. Circulation. Heart failure 14 (11) (2021)
Michael E Nassif, Sheryl L Windsor, Barry A Borlaug, Dalane W Kitzman, Sanjiv J Shah, Fengming Tang, Yevgeniy Khariton, Ali O Malik, Taiyeb Khumri, Guillermo Umpierrez, Sumant Lamba, Kavita Sharma, Sadiya S Khan, Lokesh Chandra, Robert A Gordon, John J Ryan, Sunit-Preet Chaudhry, Susan M Joseph, Chen H Chow, Manreet K Kanwar, Michael Pursley, Elias S Siraj, Gregory D Lewis, Barry S Clemson, Michael W Fong, Mikhail Naum Kosiborod
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial. Nature medicine 27 (11) (2021)
David D Berg, Kieran F Docherty, Naveed Sattar, Petr Jarolim, Paul I Welsh, Pardeep S Jhund, Inder S Anand, Vijay K Chopra, Rudolf A de Boer, Mikhail Naum Kosiborod, Jose Carlos Nicolau, Eileen O'Meara, Morten Schou, Ann Hammarstedt, Anna-Maria Langkilde, Daniel Lindholm, Mikaela Sjöstrand, John Joseph Valentine McMurray, Marc S Sabatine, David A Morrow
Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients with Heart Failure with Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial. Circulation (2021)
Nitchakarn Laichuthai, Muhammad Abdul-Ghani, Mikhail Naum Kosiborod, Wasita Warachit Parksook, Stephen J Kerr, Ralph A De Fronzo
Newly Discovered Abnormal Glucose Tolerance in Patients With Acute Myocardial Infarction and Cardiovascular Outcomes: A Meta-analysis. Diabetes care 43 (8) (2021)
Rose A Gubitosi-Klug, Xiaoyu Gao, Pradipta R Ray, Ian H de Boer, Neill White, Lloyd P Aiello, Ryan Miller, Jerry Palmer, William Tamborlane, Amisha Wallia, Mikhail Naum Kosiborod, John M Lachin, Ionut Bebu, null null
Associations of Microvascular Complications With the Risk of Cardiovascular Disease in Type 1 Diabetes. Diabetes care 44 (7) (2021)
Michael E Nassif, Sheryl L Windsor, Fengming Tang, Mansoor Husain, Catherine M Viscoli, Darren K McGuire, Bertram Pitt, Benjamin M Scirica, Bethany Austin, Michael W Fong, Shane J LaRue, Guillermo E Umpierrez, Justin Hartupee, Yevgeniy Khariton, Ali O Malik, Modele O Ogunniyi, Nanette K Wenger, Mikhail Naum Kosiborod
Dapagliflozin effects on lung fluid volumes in patients with heart failure and reduced ejection fraction: Results from the DEFINE-HF trial. Diabetes, obesity & metabolism 23 (6) (2021)
Merrill Thomas, Melissa Magwire, Kensey L Gosch, Yasser Sammour, Rane Mehta, James O'Keefe, Michael E Nassif, Mikhail Naum Kosiborod
Cardiometabolic Center of Excellence: A Novel Care Delivery Model for Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes. Circulation. Cardiovascular quality and outcomes 14 (10) (2021)
Mikhail Naum Kosiborod, Otavio Berwanger, Gary G Koch, Felipe Martinez, Omar Mukhtar, Subodh Verma, Vijay Chopra, Ali Javaheri, Philip Ambery, Samvel B Gasparyan, Joan Buenconsejo, C David Sjöström, Anna Maria Langkilde, Jan Oscarsson, Russell Esterline
Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study. Diabetes, obesity & metabolism 23 (4) (2021)
Catherine M Viscoli, Kieran F Docherty, Lars Køber, Mikhail Naum Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Scott D Solomon, Subodh Verma, Jan Bělohlávek, Michael Böhm, Chern-En Chiang, Rudolf A de Boer, Mirta Diez, Andre Dukát, Charlotta E A Ljungman, Olof Bengtsson, Anna Maria Langkilde, Mikaela Sjöstrand, Pardeep S Jhund, John Joseph Valentine McMurray, null null
Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF. Diabetes care 44 (2) (2020)
Michael E Nassif, Mikhail Naum Kosiborod
Effects of sodium glucose cotransporter type 2 inhibitors on heart failure. Diabetes, obesity & metabolism (2020)
Eun Sil Koh, Kyungdo Han, You-Seon Nam, Eric T Wittbrodt, Peter Fenici, Mikhail Naum Kosiborod, Hiddo J Lambers Heerspink, Soon-Jib Yoo, Hyuk-Sang Kwon
Renal outcomes and all-cause death associated with sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL 3 Korea). Diabetes, obesity & metabolism 23 (2) (2020)
Kieran F Docherty, Pardeep S Jhund, Olof Bengtsson, David L DeMets, Catherine M Viscoli, Lars Køber, Mikhail Naum Kosiborod, Anna Maria Langkilde, Felipe A Martinez, Marc S Sabatine, Mikaela Sjöstrand, Scott D Solomon, John Joseph Valentine McMurray, null null
Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy. Diabetes care 43 (11) (2020)
Krishna K Patel, Marília Brito Gomes, Bernard Charbonnel, Hungta Chen, Javier Cid-Ruzafa, Peter Fenici, Niklas Hammar, Li-Nong Ji, Kevin F Kennedy, Kamlesh Khunti F MedSci, Mikhail Naum Kosiborod, Stuart J Pocock, Marina V Shestakova, Iichiro Shimomura, Filip Surmont, Hirotaka Watada, Suzanne V Arnold
Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: Insights from the DISCOVER study. Diabetes, obesity & metabolism 23 (1) (2020)
Ionut Bebu, David S Schade, Barbara H Braffett, Mikhail Naum Kosiborod, Maria F Lopes-Virella, Elsayed Z Soliman, William H Herman, David A Bluemke, Amisha Wallia, Trevor Orchard, John M Lachin, null null
Risk Factors for First and Subsequent CVD Events in Type 1 Diabetes: The DCCT/EDIC Study. Diabetes care 43 (4) (2020)
Phil McEwan, Hayley Bennett, Kamlesh Khunti, John P H Wilding, Christopher Edmonds, Marcus Thuresson, Eric T Wittbrodt, Peter Fenici, Mikhail Naum Kosiborod
Assessing the cost-effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus: A comprehensive economic evaluation using clinical trial and real-world evidence. Diabetes, obesity & metabolism 22 (12) (2020)
Eric T Wittbrodt, David Chamberlain, Suzanne V Arnold, Fengming Tang, Mikhail Naum Kosiborod
Eligibility of patients with type 2 diabetes for sodium-glucose co-transporter-2 inhibitor cardiovascular outcomes trials: An assessment using the Diabetes Collaborative Registry. Diabetes, obesity & metabolism 21 (8) (2019)
Antonio Nicolucci, Bernard Charbonnel, Marília Brito Gomes, Kamlesh Khunti F MedSci, Mikhail Naum Kosiborod, Marina V Shestakova, Iichiro Shimomura, Hirotaka Watada, Hungta Chen, Javier Cid-Ruzafa, Peter Fenici, Niklas Hammar, Filip Surmont, Fengming Tang, Stuart Pocock
Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second-line therapy: Results from the global DISCOVER study programme. Diabetes, obesity & metabolism 21 (11) (2019)
Wenjun Fan, Yang Song, Silvio E Inzucchi, Laurence Sperling, Christopher P Cannon, Suzanne V Arnold, Mikhail Naum Kosiborod, Nathan D Wong
Composite cardiovascular risk factor target achievement and its predictors in US adults with diabetes: The Diabetes Collaborative Registry. Diabetes, obesity & metabolism 21 (5) (2019)
Suzanne V Arnold, Leo Seman, Fengming Tang, Poghni A Peri-Okonny, Keith C Ferdinand, Sanjeev N Mehta, Abhinav Goyal, Laurence S Sperling, Mikhail Naum Kosiborod
Real-world opportunity of empagliflozin to improve blood pressure control in African American patients with type 2 diabetes: A National Cardiovascular Data Registry "research-to-practice" project from the diabetes collaborative registry. Diabetes, obesity & metabolism 21 (2) (2018)
Mikhail Naum Kosiborod, Marilia B Gomes, Antonio Nicolucci, Stuart Pocock, Wolfgang Rathmann, Marina V Shestakova, Hirotaka Watada, Iichiro Shimomura, Hungta Chen, Javier Cid-Ruzafa, Peter Fenici, Niklas Hammar, Filip Surmont, Fengming Tang, Kamlesh Khunti, null null
Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program). Cardiovascular diabetology 17 (1) (2018)
Suzanne V Arnold, Jonathan Yap, Carolyn S P Lam, Fengming Tang, Wan T Tay, Tiew H K Teng, Darren K McGuire, James L Januzzi, Gregg C Fonarow, Frederick A Masoudi, Mikhail Naum Kosiborod
Management of patients with diabetes and heart failure with reduced ejection fraction: An international comparison. Diabetes, obesity & metabolism 21 (2) (2018)
Suzanne V Arnold, Mikhail Naum Kosiborod, Jingyan Wang, Peter Fenici, Goran Gannedahl, Robert J LoCasale
Burden of cardio-renal-metabolic conditions in adults with type 2 diabetes within the Diabetes Collaborative Registry. Diabetes, obesity & metabolism 20 (8) (2018)
Marcus Thuresson, Matthew A Cavender, Alex Z Fu, John P Wilding, Kamlesh Khunti F MedSci, Reinhard W Holl, Anna Norhammar, Kåre Inge Birkeland, Marit Eika Jorgensen, Eric Wittbrodt, Niklas Hammar, Peter Fenici, Mikhail Naum Kosiborod, null null
Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10. Diabetes care 41 (6) (2018)